Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

Recruiting

Phase 3

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active SurveillanceTrial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

Sponsor:

University of Texas Southwestern Medical Center

Code:

NCT03769766

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Curcumin

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by University of Texas Southwestern Medical Center on 2024-12-13.